Showing results (1031-1040 of 1,300) with videos related to
Sort By:
Pageof 130
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 27, 2016
Cocaine-induced behavioral sensitization decreases the expression of endocannabinoid signaling-related proteins in the mouse hippocampusEduardo Blanco, Pablo Galeano, Ana Palomino, et al.Biochemical Pharmacology|August 12, 2018
Pharmacological blockade of fatty acid amide hydrolase (FAAH) by URB597 improves memory and changes the phenotype of hippocampal microglia despite ethanol exposurePatricia Rivera, María Del Mar Fernández-Arjona, Daniel Silva-Peña, et al.The American Journal of Medicine|November 26, 2008
Gender differences in office and ambulatory control of hypertensionJosé R Banegas, Julián Segura, Alejandro de la Sierra, et al.The Journal of Endocrinology|September 3, 2011
A role for the putative cannabinoid receptor GPR55 in the islets of LangerhansSilvana Y Romero-Zerbo, Alex Rafacho, Adenis Díaz-Arteaga, et al.Alcohol and Alcoholism (Oxford, Oxfordshire)|November 1, 2017
Inclusion of Alcoholic Associations Into a Public Treatment Programme for Alcoholism Improves Outcomes During the Treatment and Continuing Care Period: A 6-Year ExperienceGabriel Rubio, Marta Marín, Francisco Arias, et al.Addiction Biology|August 21, 2020
Abrupt cessation of reboxetine along alcohol deprivation results in alcohol intake escalation after reinstatement of drinkingAntonio Ballesta, Francisco Alen, Laura Orio, et al.Environment International|March 14, 2024
Exposure to green spaces, cardiovascular risk biomarkers and incident cardiovascular disease in older adults: The Seniors-Enrica II cohortCara Scheer, Elena Plans-Beriso, Roberto Pastor-Barriuso, et al.Neuropharmacology|June 6, 2006
Antiobesity effects of the novel in vivo neutral cannabinoid receptor antagonist 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-3-hexyl-1H-1,2,4-triazole--LH 21Francisco Javier Pavon, Ainhoa Bilbao, Laura Hernández-Folgado, et al.Multiple Sclerosis and Related Disorders|October 21, 2022
B-lymphocyte-guided retreatment contributes to establish good effectiveness and safety profile in MS patients treated with rituximabJuan Luis Chico-García, Fernando Rodríguez-Jorge, Raquel Sainz-Amo, et al.BMC Public Health|August 9, 2011
Rationale and methods of the multicenter randomised trial of a heart failure management programme among geriatric patients (HF-Geriatrics)Carlos Rodríguez Pascual, Emilio Paredes Galán, Jose Luis Gonzalez Guerrero, et al.Pageof 130